文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

子宫内膜癌:强调重叠和独特形态及免疫组织化学特征的综述。

Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.

机构信息

Centro Hospitalar S. João, University of Porto, Portugal.

出版信息

Adv Anat Pathol. 2011 Nov;18(6):415-37. doi: 10.1097/PAP.0b013e318234ab18.


DOI:10.1097/PAP.0b013e318234ab18
PMID:21993268
Abstract

This review focuses on the most common diagnostic pitfalls and helpful morphologic and immunohistochemical markers in the differential diagnosis between the different subtypes of endometrial carcinomas, including: (1) endometrioid versus serous glandular carcinoma, (2) papillary endometrioid (not otherwise specified, villoglandular and nonvillous variants) versus serous carcinoma, (3) endometrioid carcinoma with spindle cells, hyalinization, and heterologous components versus malignant mixed müllerian tumor, (4) high-grade endometrioid versus serous carcinoma, (5) high-grade endometrioid carcinoma versus dedifferentiated or undifferentiated carcinoma, (6) endometrioid carcinoma with clear cells versus clear cell carcinoma, (7) clear cell versus serous carcinoma, (8) undifferentiated versus neuroendocrine carcinoma, (9) carcinoma of mixed cell types versus carcinoma with ambiguous features or variant morphology, (10) Lynch syndrome-related endometrial carcinomas, (11) high-grade or undifferentiated carcinoma versus nonepithelial uterine tumors. As carcinomas in the endometrium are not always primary, this review also discusses the differential diagnosis between endometrial carcinomas and other gynecological malignancies such as endocervical (glandular) and ovarian/peritoneal serous carcinoma, as well as with extra-gynecologic metastases (mainly breast and colon).

摘要

这篇综述重点讨论了不同类型子宫内膜癌之间鉴别诊断中最常见的诊断陷阱和有帮助的形态学和免疫组织化学标志物,包括:(1)子宫内膜样癌与浆液性腺癌,(2)乳头状子宫内膜样癌(非特指、绒毛状和非绒毛状变异型)与浆液性腺癌,(3)伴梭形细胞、玻璃样变和异源性成分的子宫内膜样癌与恶性混合性米勒管瘤,(4)高级别子宫内膜样癌与浆液性腺癌,(5)高级别子宫内膜样癌与去分化或未分化癌,(6)伴透明细胞的子宫内膜样癌与透明细胞癌,(7)透明细胞癌与浆液性腺癌,(8)未分化癌与神经内分泌癌,(9)混合细胞类型癌与具有模糊特征或变异形态的癌,(10)林奇综合征相关的子宫内膜癌,(11)高级别或未分化癌与非上皮性子宫肿瘤。由于子宫内膜癌并不总是原发性的,因此这篇综述还讨论了子宫内膜癌与其他妇科恶性肿瘤(如宫颈内膜(腺体)和卵巢/腹膜浆液性腺癌)以及与妇科外转移(主要是乳腺和结肠)之间的鉴别诊断。

相似文献

[1]
Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.

Adv Anat Pathol. 2011-11

[2]
Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

Am J Surg Pathol. 2009-10

[3]
Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.

Am J Surg Pathol. 2012-12

[4]
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

Pathology. 2011-8

[5]
Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.

Gynecol Oncol. 2001-5

[6]
A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.

Verh Dtsch Ges Pathol. 1997

[7]
HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.

Histopathology. 2012-1-17

[8]
p16 expression in the female genital tract and its value in diagnosis.

Adv Anat Pathol. 2006-1

[9]
Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.

Clin Cancer Res. 2005-5-1

[10]
Minor serous and clear cell components adversely affect prognosis in ''mixed-type'' endometrial carcinomas: a clinicopathologic study of 36 stage-I cases.

Reprod Sci. 2010-4-14

引用本文的文献

[1]
Neuroendocrine Tumors of the Endometrium: a Case Series with Clinico-Pathological Analysis and Review of Literature.

Indian J Surg Oncol. 2025-2

[2]
Undifferentiated endometrial carcinoma diagnosed during perimenopausal hormone therapy: a case report and literature review.

Front Oncol. 2024-11-22

[3]
Clinicopathological Significance of Defective DNA Mismatch Repair in Endometrial Carcinoma: A Single-Center Study From Bahrain.

Cureus. 2024-8-20

[4]
The evolving landscape of immunohistochemistry in cervical and uterine carcinoma in gynecologic oncology: current status and future directions.

Obstet Gynecol Sci. 2024-9

[5]
New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles.

Pathol Int. 2024-10

[6]
Narrative review on the evolving role of HER2/neu targeting in uterine serous cancers.

Ann Transl Med. 2024-8-1

[7]
Unusual spread of cervical adenocarcinoma to the endometrium and left fallopian tube: a case report and literature review.

Ann Med Surg (Lond). 2024-5-15

[8]
Estrogen Receptor (ER) and Progesterone Receptor (PgR) Expression in Endometrial Cancer-An Immunohistochemical Assessment.

Diagnostics (Basel). 2024-2-1

[9]
Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas.

Curr Health Sci J. 2022

[10]
Neuroendocrine Neoplasms of the Gynecologic Tract.

Cancers (Basel). 2022-4-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索